Intestinal drug transporter expression and the impact of grapefruit juice in humans. Glaeser H, Bailey DG, Dresser GK, Gregor JC, Schwarz UI, McGrath JS, Jolicoeur E, Lee W, Leake BF, Tirona RG, Kim RB (2007) Clin Pharmacol Ther 81: 362-70 Are herbal products dietary supplements or drugs? An important question for public safety. Stein CM (2002) Clin Pharmacol Ther 71: 411-3 Identification of functionally variant MDR1 alleles among European Americans and African Americans. Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwarz UI, Taylor A, Xie HG, McKinsey J, Zhou S, Lan LB, Schuetz JD, Schuetz EG, Wilkinson GR (2001) Clin Pharmacol Ther 70: 189-99 Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB (2002) Clin Pharmacol Ther 71: 11-20 Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Bailey DG, Dresser GK, Leake BF, Kim RB (2007) Clin Pharmacol Ther 81: 495-502 Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation. Yun CH, Okerholm RA, Guengerich FP (1993) Drug Metab Dispos 21: 403-9 OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB (1999) Drug Metab Dispos 27: 866-71
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.